ArticleJournal of medicine and life2026
Segmental and global amyloid burden and myocardial mechanics: a multimodality imaging comparison.
Article in Journal of medicine and life, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bone scintigraphy with bisphosphonate tracers is a cornerstone of noninvasive diagnosis in transthyretin amyloid cardiomyopathy (ATTR-CM). However, methods for estimating the extent and regional distribution of myocardial amyloid burden using single-photon emission computed tomography (SPECT) remain insufficiently validated. This study aimed to evaluate whether global and segmental myocardial radiotracer uptake, assessed by bisphosphonate SPECT, correlates with myocardial amyloid infiltration measured by cardiac magnetic resonance (cMRI)-derived extracellular volume (ECV), and to explore the relationship between these imaging markers and myocardial mechanics. Twenty-seven patients with ATTR-CM who underwent multimodality imaging with bisphosphonate SPECT, cMRI, and transthoracic echocardiography (TTE) between 2017 and 2025 were retrospectively screened. Sixteen patients with complete segmental datasets across all imaging modalities were included in the final analysis. Segmental mixed-effects models were used to account for clustering of myocardial segments within patients. Segmental extent of amyloid burden assessed by SPECT was significantly associated with segmental ECV (β = 0.042, SE = 0.010, t = 4.22), indicating higher radiotracer retention in segments with greater myocardial infiltration. Segmental ECV demonstrated a strong association with impaired longitudinal strain (β = 0.269, SE = 0.043, t = 6.22). In contrast, the direct relationship between radiotracer uptake and longitudinal strain was weaker and not statistically significant (β = 0.016, SE = 0.010, t = 1.60). In combined models, ECV remained independently associated with strain (β = 0.266, SE = 0.045, t = 5.96), whereas radiotracer uptake lost significance (β = 0.003, SE = 0.010, t = 0.29). At the global level, global extent amyloid burden (GEAB) correlated significantly with ECV (β = 0.435,
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.